While previous studies suggested impaired insulinotropic effect of GIP in type 2 diabetes patients [16], a recent study proposed a certain degree of contribution of GIP to the incretin-stimulated insulin secretion observed in type 2 diabetes patients using the hyperglycemic glucose clamp together with duodenal nutrition perfusion [13]. The gene discussed is INS; the disease is type 2 diabetes mellitus.